MIRA INFORM REPORT

 

 

Report Date :

13.03.2013

 

IDENTIFICATION DETAILS

 

Name :

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

 

 

Formerly Known As :

SUNWARD CHEMICAL INDUSTRIAL COMPANY PRIVATE LIMITED

 

 

Registered Office :

371 Beach Road #17-04 Keypoint Singapore 199597

 

 

 

 

Country :

Singapore

 

 

 

 

Financials (as on) :

30.06.2011

 

 

 

 

Date of Incorporation :

10.05.1968

 

 

 

 

Com. Reg. No.:

196800189K

 

 

 

 

Legal Form :

Limited Private Company

 

 

 

 

Line of Business :

Manufacture of Other Biological Products and Preparations For Human Use

 

 

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Singapore

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

SINGAPORE - ECONOMIC OVERVIEW

 

Singapore has a highly developed and successful free-market economy. It enjoys a remarkably open and corruption-free environment, stable prices, and a per capita GDP higher than that of most developed countries. The economy depends heavily on exports, particularly in consumer electronics, information technology products, pharmaceuticals, and on a growing financial services sector. Real GDP growth averaged 8.6% between 2004 and 2007. The economy contracted 1.0% in 2009 as a result of the global financial crisis, but rebounded 14.8% in 2010 and 4.9% in 2011, on the strength of renewed exports. Over the longer term, the government hopes to establish a new growth path that focuses on raising productivity, which has sunk to a compound annual growth rate of just 1.8% in the last decade. Singapore has attracted major investments in pharmaceuticals and medical technology production and will continue efforts to establish Singapore as Southeast Asia's financial and high-tech hub.

Source : CIA

 

Company Name:

Registered Number:

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

196800189K

 

Date Incorporated:

Registered Office:

Telephone Number:

10/05/1968

371 BEACH ROAD #17-04 KEYPOINT SINGAPORE 199597

6265 6022

Age of Company:

Website:

Industry Type:

44

www.sunwardpharma.com

MANUFACTURING

 

 

Risk Dashboard

Days Beyond Terms

Trend:

No. of Litigation Counts:

Company DTC:

1

34

Worse off than last month;last month the entity took 109 days to pay

No. of Charges(s):
3

Industry DTC

 

26

 

Directors

 

Corporate Structure

Number of Current Directors

3

Holding Company:

NA

Number that are shareholders

13

No. of Subsidiaries & Associated Companies:

2

 

EXECUTIVE SUMMARY

 

Company Name

:

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Registration No

:

196800189K

Date of Registration

:

10/05/1968

Former Name

:

SUNWARD CHEMICAL INDUSTRIAL COMPANY PRIVATE LIMITED Eff. date : 10/05/1968 Eff. date : 10/05/1968

Date of Change of Name

:

20/12/1989

Type of Company

:

LIMITED PRIVATE COMPANY

Registered Address

:

371 BEACH ROAD #17-04 KEYPOINT SINGAPORE 199597

Date of Change of Address

:

06/04/2000

Contact No.

:

6265 6022

Fax No.

:

6265 8276

Website

:

www.sunwardpharma.com

Head Office

:

11 Wan Lee Road Singapore 627943, Singapore

Registered Activities

:

MANUFACTURE OF OTHER BIOLOGICAL PRODUCTS AND PREPARATIONS FOR HUMAN USE

MANUF MEDICINAL & PHARMACEUTICAL PRODS

Issued Ordinary Capital*

:

$3,119,400.00 SINGAPORE, DOLLARS ,NO. OF SHARE : 31,194

Issued Preference Capital

:

NA

Paid-Up Ordinary Capital

:

$3,119,400.00 SINGAPORE, DOLLARS

* Number of Shares includes number of Issued Treasury Shares

Issued Treasury Capital

:

NA

Paid-Up Treasury Capital

:

NA

No. of Local Subsidiaries

:

2

No. of Local Associates

:

NA

Auditor

:

M Y CHAU & CO

Bankers / Financiers

:

UNITED OVERSEAS BANK LIMITED

Turnover

:

SGD - SIN 26,447,951.00 (FY2011)

Net Worth

:

SGD - SIN 21,459,941.00 (FY2011)

No. of Bank Charges

:

3

No. of Litigation Suits

:

1

S1000 / SME 1000 / FG50 Ranking

:

422 POSITION IN SME 1000 Companies Ranked by Sales/Turnover (2010/2011)

404 POSITION IN SME 1000 Companies Ranked by Net Profit (2010/2011)

454 POSITION IN SME 1000 Companies Ranked by Sales/Turnover (2009/2010)

256 POSITION IN SME 1000 Companies Ranked by Net Profit (2009/2010)

414 POSITION IN SME 500 Companies Ranked by Sales/Turnover (2008/2009)

Compounded Annual Growth Rate (CAGR)

:

9.92% (4 years)

 

 

SHAREHOLDER DETAILS

 

NAME

:

JUNG JIUNN DER

SHAREHOLDER ID

:

S2181641H

NATIONALITY

:

SINGAPORE P.R.

ADDRESS

:

17 JALAN JITONG SELETAR HILLS ESTATE SINGAPORE 809131

NO. OF ORD SHARES

:

10,787

% OF SHAREHOLDING

:

34.6%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

JUNG YI HUEY

SHAREHOLDER ID

:

S2179447C

NATIONALITY

:

SINGAPORE P.R.

ADDRESS

:

53 CROWHURST DRIVE STAR MANSIONS SINGAPORE 557932

NO. OF ORD SHARES

:

5,631

% OF SHAREHOLDING

:

18.1%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

JUNG YU PEN (Deceased)

SHAREHOLDER ID

:

S2176097H

NATIONALITY

:

SINGAPORE P.R.

ADDRESS

:

3 KASAI ROAD SELETAR HILLS ESTATE SINGAPORE 808251

NO. OF ORD SHARES

:

5,000

% OF SHAREHOLDING

:

16%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

JUNG YI HWA

SHAREHOLDER ID

:

S2177090F

NATIONALITY

:

SINGAPORE P.R.

ADDRESS

:

3 KASAI ROAD SELETAR HILLS ESTATE SINGAPORE 808251

NO. OF ORD SHARES

:

5,000

% OF SHAREHOLDING

:

16%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

LIN GAU DE

SHAREHOLDER ID

:

S2189842B

NATIONALITY

:

SINGAPORE P.R.

ADDRESS

:

NO.118 SECTION 3 CHUNG GANG ROAD 407 TAI CHUNG TAIWAN R.O.C.

NO. OF ORD SHARES

:

2,500

% OF SHAREHOLDING

:

8%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

LOH MEW LENG

SHAREHOLDER ID

:

S0282728Z

NATIONALITY

:

SINGAPORE CITIZEN

ADDRESS

:

85 CHEVIOT HILL FRANKEL ESTATE SINGAPORE 459667

NO. OF ORD SHARES

:

700

% OF SHAREHOLDING

:

2.2%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

WEI CHUN JU

SHAREHOLDER ID

:

S2202353E

NATIONALITY

:

SINGAPORE P.R.

ADDRESS

:

17 JALAN JITONG SELETAR HILLS ESTATE SINGAPORE 809131

NO. OF ORD SHARES

:

451

% OF SHAREHOLDING

:

1.4%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

TAN GEE BENG PRIVATE LIMITED

SHAREHOLDER ID

:

196700431Z

NATIONALITY

:

SINGAPORE

ADDRESS

:

95 AMOY STREET SINGAPORE 069915

NO. OF ORD SHARES

:

450

% OF SHAREHOLDING

:

1.4%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

LIM AH KENG

SHAREHOLDER ID

:

S2134537G

NATIONALITY

:

SINGAPORE CITIZEN

ADDRESS

:

40A LORONG 6 GEYLANG SINGAPORE 399194

NO. OF ORD SHARES

:

363

% OF SHAREHOLDING

:

1.2%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

GAN HOCK SENG

SHAREHOLDER ID

:

5629527

NATIONALITY

:

MALAYSIAN

ADDRESS

:

NO. 1157 JALAN RJ 3/14 TAMAN RASAH JAYA 70300 SEREMBAN NEGIRI SEMBILAN WEST MALAYSIA

NO. OF ORD SHARES

:

110

% OF SHAREHOLDING

:

0.4%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

GAN HOCK CHOON

SHAREHOLDER ID

:

6132723

NATIONALITY

:

MALAYSIAN

ADDRESS

:

NO. 1157 JALAN RJ 3/14 TAMAN RASAH JAYA 70300 SEREMBAN NEGIRI SEMBILAN WEST MALAYSIA

NO. OF ORD SHARES

:

109

% OF SHAREHOLDING

:

0.3%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

TAN QUEE CHUAN

SHAREHOLDER ID

:

S0557078F

NATIONALITY

:

SINGAPORE CITIZEN

ADDRESS

:

29 JALAN DERMAWAN POPULAR ESTATE SINGAPORE 668974

NO. OF ORD SHARES

:

63

% OF SHAREHOLDING

:

0.2%

CURRENCY

:

SINGAPORE, DOLLARS

 

NAME

:

TAN CHENG CHOW @ TAN GEE BENG

SHAREHOLDER ID

:

S0609465A

NATIONALITY

:

SINGAPORE CITIZEN

ADDRESS

:

55 HILLSIDE DRIVE SINGAPORE 549004

NO. OF ORD SHARES

:

30

% OF SHAREHOLDING

:

0.1%

CURRENCY

:

SINGAPORE, DOLLARS

 

 

OFFICER DETAILS

 

NAME

:

NG SIEW HONG

ADDRESS

:

461 CLEMENTI AVENUE 3 #15-614 SINGAPORE 120461

POSITION

:

SECRETARY

 

DATE OF APPT

:

01/06/2006

 

NATIONALITY

:

SINGAPORE CITIZEN

I/C PASSPORT

:

S0245049F

 

NAME

:

LOH MEW LENG

ADDRESS

:

85 CHEVIOT HILL FRANKEL ESTATE SINGAPORE 459667

POSITION

:

DIRECTOR

DATE OF APPT

:

06/12/1969

NATIONALITY

:

SINGAPORE CITIZEN

I/C PASSPORT

:

S0282728Z

 

NAME

:

JUNG YI HUEY

ADDRESS

:

53 CROWHURST DRIVE STAR MANSIONS SINGAPORE 557932

POSITION

:

DIRECTOR

DATE OF APPT

:

30/12/1987

NATIONALITY

:

SINGAPORE P.R.

I/C PASSPORT

:

S2179447C

 

NAME

:

JUNG JIUNN DER

ADDRESS

:

17 JALAN JITONG SELETAR HILLS ESTATE SINGAPORE 809131

POSITION

:

DIRECTOR

DATE OF APPT

:

17/12/1989

NATIONALITY

:

SINGAPORE P.R.

I/C PASSPORT

:

S2181641H

 

 

KEY PERSONNEL PROFILE

 

Name:

JUNG JIUNN DER

NRIC Number:

S2181641H

Available Address:

17 JALAN JITONG SELETAR HILLS ESTATE  SINGAPORE 809131

 

 

Current Business Interest

 

No.

Name

Position

Appt Date

#of Share

%

1

RESEARCH LABORATORY COSMETIQUES PTE. LTD.

DIRECTOR

02/10/2003

-

-

2

SPECTRUM HEALTH PROMOTION PTE LTD

DIRECTOR

03/01/1990

-

-

3

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

DIRECTOR

17/12/1989

10787

34.58

4

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

MANAGING DIRECTOR

22/03/1996

10787

34.58

 

 

Previous Business

 

No.

Name

 

 

Status

Position

Appt Date

Last Known Inactive Date

1

GIRAFFES PHARMACEUTICAL PTE LTD

STRUCK OFF

DIRECTOR

08/07/1997

-

2

GIRAFFES PHARMACEUTICAL PTE LTD

STRUCK OFF

SHAREHOLDER

-

-

3

LUYE-SUNWARD PHARM PTE. LTD.

STRUCK OFF

DIRECTOR

11/05/2005

-

4

LUYE-SUNWARD PHARM PTE. LTD.

STRUCK OFF

SHAREHOLDER

-

-

 

Bankruptcy Record

 

Case No.

Year

Date of Filing

Petitioner Name

Amount

No Trace

 

 

 

 

 

 

Litigation Search – Writ of Summons

 

Court

Case No.

Transfer

Year

Date of Filing

Amount

Cause Category

No Trace

 

 

 

 

 

 

 

 

SUBSIDIARIES AND ASSOCIATE COMPANIES

 

Company

Shareholdings (%)

 

SPECTRUM HEALTH PROMOTION PTE LTD

100

RESEARCH LABORATORY COSMETIQUES PTE. LTD.

100

 

BANKERS/ FINANCIERS

 

Subject enjoys a normal banking routine with its bankers. To date, there have been 3 bank charges registered against Subject by its bankers. The charge numbers are:

 

1)

Charge No.

:

C201102703

 

Date of Registration

:

03/03/2011

 

Chargee

:

UNITED OVERSEAS BANK LIMITED

 

Amount Secured  and Currency

:

All Monies

 

Address

:

80 RAFFLES PLACE UOB PLAZA SINGAPORE 048624

 

2)

Charge No.

:

C200907698

 

Date of Registration

:

24/11/2009

 

Chargee

:

UNITED OVERSEAS BANK LIMITED

 

Amount Secured  and Currency

:

All Monies

 

Address

:

80 RAFFLES PLACE UOB PLAZA SINGAPORE 048624

 

3)

Charge No.

:

C200907697

 

Date of Registration

:

24/11/2009

 

Chargee

:

UNITED OVERSEAS BANK LIMITED

 

Amount Secured  and Currency

:

All Monies

 

Address

:

80 RAFFLES PLACE UOB PLAZA SINGAPORE 048624

 

 

 

             

LITIGATION

 

To date, there have been 1  litigation suits filed against Subject.

 

 

Current Year

On/After 01 Jan 2012

Past Years

Bef 01 Jan 2012

 

Court (Claim under normal circumstances)

Magistrate (< $80,000)

0

1

District ($80,000 - $250,000)

0

0

High (>$250,000)

0

0

 

Winding Up Trace

 

No

In litigation/Dissolved/Struck Off/In receivership

No

 

The details are as follows:

 

1)

Court

:

Magistrate Court

 

Case No.

:

2858

 

Transfer

:

-

 

Date of Filing

:

02/02/2009

 

Amount

:

3,427.80

 

Cause

:

Tort - Negligence (Motor Accidents With Injury)

 

Case Status

:

CONCLUDED

 

Plaintiff

:

KWOK LILIAN

 

 

COMPLIANCE

 

Date of Last AGM

:

30/12/2011

Date of Last AR

:

26/01/2012

Date of A/C Laid At Last AGM

:

30/06/2011
 

COMPLIANCE RATING FOR ANNUAL FILING

 

ANNUAL GENERAL MEETING,ANNUAL RETURN AND ACCOUNTS UP-TO-DATE

 

Note:

 

Provided by ACRA (Accounting and Corporate Regulatory Authority), the Compliance Rating for Annual Filing measures a company’s compliance with the provisions under S175, S197 or S201 of the Companies Act, Cap. 50.

 

Applicable to all “Live” locally incorporated companies except for the Limited Partnerships, Limited Liability Partnerships, Business Entities, Foreign Companies and Public Accounting Firms, the rating provide information on whether a company is up-to-date with the holding of its Annual General Meeting (AGM) with up-to-date financial statements and filing of its Annual Return (AR).

 

For more information: www.acra.gov.sg/compliance

 

 

FINANCIAL HIGHLIGHTS

 

Financial Figures

Group

 

JUN 2011

% Change

JUN 2010

JUN 2009

JUN 2008

JUN 2007

Currency

SGD - SIN

 

SGD - SIN

SGD - SIN

SGD - SIN

SGD - SIN

Profit and Loss Key Figures

 

 

 

 

 

 

Turnover

26,447,951

20.53

21,942,624

22,729,711

17,108,173

18,118,776

Profit/(Loss) Before Tax

4,898,717

48.04

3,309,091

4,556,205

2,618,931

3,047,094

Profit After Tax attributable to Shareholders

3,785,361

60.07

2,364,815

3,456,218

1,997,271

2,408,093

 

 

 

 

 

 

 

Balance Sheet Key Figures

 

 

 

 

 

 

Total Assets

28,752,369

17.88

24,391,412

21,350,906

15,552,365

14,598,987

Current Assets

17,824,452

11.96

15,920,265

14,545,161

10,730,820

10,136,823

Non Current Assets

10,927,917

29.00

8,471,147

6,805,745

4,821,545

4,462,164

 

 

 

 

 

 

 

Total Liabilities

7,292,428

14.34

6,377,931

5,751,745

3,414,641

4,054,685

Current Liabilities

4,363,831

29.70

3,364,439

4,770,590

2,859,703

3,482,633

Non Current Liabilities

2,928,597

-2.82

3,013,492

981,155

554,938

572,052

 

 

 

 

 

 

 

Shareholders' Funds

21,459,941

19.13

18,013,481

15,599,161

12,137,724

10,544,302

Share Capital

3,119,400

0.00

3,119,400

3,119,400

3,119,400

3,119,400

Total Reserves

18,340,541

23.14

14,894,081

12,479,761

9,018,324

7,424,902

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL RATIOS

 

 

Group

 

JUN 2011

JUN 2010

JUN 2009

JUN 2008

JUN 2007

Growth %

 

 

 

 

 

Year-on-Year Growth

20.53

-3.46

32.86

-5.58

NA

 

 

 

 

 

 

Profitability

 

 

 

 

 

Profit Margin (%)

14.31

10.78

15.21

11.67

13.29

Return on Equity (%)

17.64

13.13

22.16

16.46

22.84

Return on Assets (%)

13.17

9.70

16.19

12.84

16.49

 

 

 

 

 

 

Leverage

 

 

 

 

 

Total Debt/Equity (Times)

0.34

0.35

0.37

0.28

0.38

Current Debt/Equity (Times)

0.20

0.19

0.31

0.24

0.33

Long Term Debt To Equity (Times)

0.14

0.17

0.06

0.05

0.05

Total Asset To Total Equity (Times)

1.34

1.35

1.37

1.28

1.38

 

 

 

 

 

 

Asset Management

 

 

 

 

 

Total Assets Turnover (Times)

0.92

0.90

1.06

1.10

1.24

Fixed Assets Turnover (Times)

2.42

2.59

3.34

3.55

4.06

 

 

 

 

 

 

Liquidity

 

 

 

 

 

Current Ratio (Times)

4.08

4.73

3.05

3.75

2.91

 

 

 

 

 

 

 

 

FINANCIAL HIGHLIGHTS

 

Financial Figures

Company

 

JUN 2010

JUN 2009

JUN 2008

JUN 2007

Currency

SGD - SIN

SGD - SIN

SGD - SIN

 

Profit and Loss Key Figures

 

 

 

 

Turnover

8,547,635

8,663,640

7,112,010

6,979,162

Profit/(Loss) Before Tax

271,822

734,918

104,545

521,136

Profit After Tax attributable

 to Shareholders

229,877

642,559

75,679

420,930

 

 

 

 

 

Balance Sheet Key Figures

 

 

 

 

Total Assets

10,399,823

8,395,738

7,133,862

5,632,850

Current Assets

5,035,614

4,599,705

4,850,672

3,209,536

Non Current Assets

5,364,209

3,796,033

2,283,190

2,423,314

 

 

 

 

 

Total Liabilities

5,415,894

3,641,686

3,022,369

1,597,036

Current Liabilities

3,112,833

3,341,183

2,761,557

1,308,666

Non Current Liabilities

2,303,061

300,503

260,812

288,370

 

 

 

 

 

Shareholders' Funds

4,983,929

4,754,052

4,111,493

4,035,814

Share Capital

3,119,400

3,119,400

3,119,400

3,119,400

Total Reserves

1,864,529

1,634,652

992,093

916,414

 

 

 

 

 

 

 

FINANCIAL RATIOS 

 

 

Company

 

JUN 2010

JUN 2009

JUN 2008

JUN 2007

Growth %

 

 

 

 

Year-on-Year Growth

NA

NA

NA

NA

 

 

 

 

 

Profitability

 

 

 

 

Profit Margin (%)

2.69

7.42

1.06

6.03

Return on Equity (%)

4.61

13.52

1.84

10.43

Return on Assets (%)

2.21

7.65

1.06

7.47

 

 

 

 

 

Leverage

 

 

 

 

Total Debt/Equity (Times)

1.09

0.77

0.74

0.40

Current Debt/Equity (Times)

0.62

0.70

0.67

0.32

Long Term Debt To Equity (Times)

0.46

0.06

0.06

0.07

Total Asset To Total Equity (Times)

2.09

1.77

1.74

1.40

 

 

 

 

 

Asset Management

 

 

 

 

Total Assets Turnover (Times)

0.82

1.03

1.00

1.24

Fixed Assets Turnover (Times)

1.59

2.28

3.11

2.88

 

 

 

 

 

Liquidity

 

 

 

 

Current Ratio (Times)

1.62

1.38

1.76

2.45

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL COMMENTARY

 

Compound Annual Growth Rate

 

The company's CAGR is 9.92% (4 years).

 

CAGR is the year-over-year growth rate of a company over a specified period. Instead of looking at the average growth rate, CAGR allow users to look at the annualized growth rate of a company over a given period, a more indicative measure of growth of a company’s performance over a given period.

 

Profitability

The group yielded a rate of net profit on sales of 14.31 per cent in FY11. The group is now able to book in SGD - SIN 0.14 of profit for every SGD - SIN of sales.

 

Liquidity

Current ratio stood at 4.08 times in FY11. This means that the group has SGD - SIN 4.08 of current assets for every SGD - SIN of current liability incurred.

 

FINANCIAL COMMENTARY

 

A minimum figure of 1.0 would be considered the lowest limit that this figure should reach. Any business that has a current ratio near 1.0 may be heading for liquidity problems, and would need to be closely monitored. A figure greater than 2.0 would be more desirable, to act as a buffer against any short-term liquidity problems, and give creditors/bank managers a degree of comfort when granting credit/finance.

 

Leverage

Total debt-to-equity ratio notched 0.34 times in FY11. This means that the group requires additional external financing of SGD - SIN 0.34 for every SGD - SIN injected into its operations.

 

Generally, a total debt-to-equity ratio of less than 0.5 times is preferred. The ratio measures the proportion of the company's reliance on external debt for financing, relative to the shareholder's fund. A lower ratio would imply a greater financial safety and operating freedom for the company.

 

 

Efficiency Ratio

Return on equity was 17.64 per cent for Subject in the current financial period. The return on equity measures the return earned on the owner's investment.  Generally, the higher this return, the better off the owner.

 

Return on assets stood at 13.17 per cent. The return on asset measures the overall effectiveness of management in generating profit with its available assets.

 

 

FINANCIAL COMMENTARY

 

Total assets turnover ratio logged at 0.92 times in FY11. This ratio measures the group's ability to make productive use of its total assets to generate sales which reflects the efficiency of the management in utilising its resources.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.54.33

UK Pound

1

Rs.80.89

Euro

1

Rs.70.73

 

 

INFORMATION DETAILS

 

Report Prepared by :

NLM

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.